This actively managed exchange-traded fund endeavors to generate returns by investing in U.S.-listed companies poised to benefit from evolving regulatory environments that promote free-market principles. Its primary focus is on industries historically burdened by extensive oversight, such as healthcare, financial services, and energy, anticipating forthcoming regulatory relief. However, the fund also allocates capital to less regulated sectors like technology and consumer goods. The strategy capitalizes on various favorable policy shifts, including reduced government intervention, tax reductions, streamlined licensing procedures, and the elimination of trade barriers. By anticipating these regulatory transformations, the fund aims to uncover undervalued opportunities and mitigate the impact of increasing regulatory burdens elsewhere. Company selection emphasizes evaluating businesses for their potential to capitalize on deregulation, assessing their adaptability, strategic initiatives, and competitive standing within their respective markets. The portfolio typically comprises between 25 and 50 holdings, with at least 80% of its assets dedicated to entities expected to gain from deregulation. Furthermore, up to 5% of the fund's assets may be channeled into exchange-traded products offering exposure to Bitcoin and Ether, thereby diversifying the portfolio and tapping into the growth potential of digital assets.